Surescripts purpose is to serve the nation with the single most trusted and capable health information network, built to increase patient safety, lower costs and ensure quality care. Since 2001, Surescripts has led the movement to turn data into actionable intelligence, and convened its network allies to enhance e-prescribing, inform care decisions and advance the healthcare industry. Visit us at surescripts.com and follow us at twitter.com/surescripts
First Databank (FDB), a subsidiary of Hearst Corporation, provides clinical drug knowledge that helps healthcare professionals make more precise medication-related decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver a wide range of valuable, useful and differentiated solutions. As the company that virtually helped to launch the medication decision support category, we offer more than three decades of experience in helping transform drug knowledge into actionable, targeted and effective solutions that improve patient safety and healthcare outcomes. For more information about First Databank, call 800-633-3453 or visit www.firstdatabank.com.
Aptus Health offers health and life sciences companies a truly connected approach to engaging healthcare professionals, consumers and other stakeholders through an array of high-value digital information channels and services. By applying this portfolio of assets—informed by rich engagement data and analytics—Aptus designs and builds integrated multichannel engagement solutions that allow its clients to connect with their customers at key points in their decision-making journeys and deliver meaningful impact at scale.
Aptus Health’s RxStart™ solution improves patients’ experience with a new recommended care plan by delivering a one-time, free trial directly to the patient’s home, along with personalized follow-up support. Healthcare providers can enroll eligible patients in the program right from within the New Crop Electronic Medical Record. visit http://www.aptushealth.com for more information
As a trusted partner and industry leader, MMIT provides formulary tools and solutions to life sciences companies, managed care organizations and electronic prescribing software vendors. Our team of pharmacists and pharmacy technicians research and interpret data on drugs and pharmacological products for nearly 5,000 health plans. This comprehensive data provides the basis for all MMIT products and services and ensures you’ll have the most accurate information and insights today – and tomorrow.
Krames is the market leader in patient education and consumer health information solutions. Over 85 percent of American hospitals, as well as leading health plans, employer groups, private practices and pharmaceutical companies use Krames’ solutions to improve quality of care, streamline workflow and lower healthcare costs. Krames also brings health literacy expertise to American Heart Association/ American Stroke Association and American Lung Association patient education through exclusive partnerships with these respected organizations. Founded in 1974, Krames remains at the leading edge of patient education with innovative programs that utilize a comprehensive suite of print, electronic and video content.
Weno Exchange LLC (WEX) is an e-Prescribing switch based in Austin, Texas that specializes in routing electronic prescriptions (eRx) between trading partners. When established in 2011, WEX was hailed as an innovative competitor in an otherwise dominated e-prescribing network market. WEX utilizes a patent-pending method, which provides the first and only service enabling electronic prescriptions to be sent to any pharmacy. In addition, WEX offers health IT trading partners a simplified process toward connectivity. WEX also boasts the industry’s highest EHR incentive revenues and pharmacy’s lowest transaction fees. WEX’s Benefit Service gives participants opportunity to provide patients and prescribers with medication histories and more cost information when they are in the process of selecting a drug, whether the patient prefers to pay cash or take advantage of a 3rd party offer or government program. The WEX Benefit program uses a patent pending method designed to assure health plans, drug sponsors, and pharmacies that their data is shown consistently and used appropriately in the market. For more information, go to www.wenoexchange.com